Quince Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Quince Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q2 2024.
  • Quince Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -73.4 %, a 129% decline year-over-year.
  • Quince Therapeutics, Inc. annual Return On Equity for 2023 was -36.4 %, a 25.6% increase from 2022.
  • Quince Therapeutics, Inc. annual Return On Equity for 2022 was -48.9 %, a 25.4% increase from 2021.
  • Quince Therapeutics, Inc. annual Return On Equity for 2021 was -65.4 %, a 66.9% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -73.4 -41.4 -129% Apr 1, 2024 Jun 30, 2024
Q1 2024 -36.8 +4.78 +11.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -36.4 +12.5 +25.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -31.1 +32 +50.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -32 +39 +54.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.6 +29.3 +41.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -48.9 +16.6 +25.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -63.1 -5.32 -9.22% Jul 1, 2022 Sep 30, 2022
Q2 2022 -71 -18.3 -34.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -70.8 -25 -54.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -65.4 -26.2 -66.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -57.7 -20 -52.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.8 -18.5 -54.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -45.8 -13.4 -41.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.2 +4.16 +9.59% Oct 1, 2020 Dec 31, 2020
Q3 2020 -37.8 +20.4 +35.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -34.2 +194 +85% Apr 1, 2020 Jun 30, 2020
Q1 2020 -32.5 -79.2 -170% Jan 1, 2020 Mar 31, 2020
Q4 2019 -43.4 -87.8 -198% Oct 1, 2019 Dec 31, 2019
Q3 2019 -58.2 Jul 1, 2019 Sep 30, 2019
Q2 2019 -228 Apr 1, 2019 Jun 30, 2019
Q1 2019 46.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 44.5 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.